Jazz Pharmaceuticals, Inc.

We are a pharmaceutical company focusing on improving the lives of patients through the development and commercialization of neurological and psychiatric products. We are committed to working closely with patients, patient advocacy groups and healthcare professionals. At Jazz Pharmaceuticals, we are creating innovative therapeutics by improving and expanding the uses of known compounds, and aggressively adding to our pharmaceutical product portfolio through licensing, acquisitions and collaborations

Contact Details: 3180 Porter Drive Palo Alto California 94304 United States of America Tel: (650) 496-3777 Fax: (650) 496-3781 Email: contact@jazzpharma.com WWW: www.orphan.com/

Loading...

Press Releases on Jazz Pharmaceuticals, Inc.:
Jazz Pharmaceuticals Announces Third Quarter 2009 Financial Results	5th November, 2009	Jazz Pharmaceuticals, Inc.	PALO ALTO, Calif., Nov. 5 /PRNewswire-FirstCall/ -- Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) today announced financial results for the third quarter ended September 30, 2009. Total revenues for the
Jazz Pharmaceuticals to Announce Third Quarter Financial Results on November 5, 2009	29th October, 2009	Jazz Pharmaceuticals, Inc.	PALO ALTO, Calif., Oct. 29 /PRNewswire-FirstCall/ -- Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) today announced that it will report its third quarter 2009 financial results on Thursday, November 5,
Jazz Pharmaceuticals Announces Second Quarter 2009 Financial Results	11th August, 2009	Jazz Pharmaceuticals, Inc.	-- Selling, general and administrative expenses are expected to remain at about $14 million per quarter for the rest of 2009 Jazz Pharmaceuticals will host an investor conference call
Jazz Pharmaceuticals Completes $7 Million Private Placement	7th July, 2009	Jazz Pharmaceuticals, Inc.	PALO ALTO, Calif., July 7, 2009 /PRNewswire-FirstCall/ -- Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) today announced the signing and closing of a private placement of an aggregate of 1,895,734 units,
Jazz Pharmaceuticals Pays Accrued Interest Under Senior Secured Notes	7th July, 2009	Jazz Pharmaceuticals, Inc.	PALO ALTO, Calif., July 7, 2009 /PRNewswire-FirstCall/ -- Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) today announced that it has paid to the holders of its senior secured notes the interest

BioNews Results for Jazz Pharmaceuticals, Inc.:
Jazz Pharmaceuticals Down 4% Since SmarTrend's Sell Recommendation	TradingMarkets:  Nov 19 2009 8:05PM Matching: jazz pharmaceuticals inc
PHT Corporation Grows Bookings by 41% Over 9 Month Period, Announces Vice Presidents' Promotion and Professional Award	Yahoo! Canada:  Nov 17 2009 2:20PM Matching: jazz pharmaceuticals inc
PHT Corporation Grows Bookings by 41% Over 9 Month Period, Announces Vice Presidents' Promotion and Profession	Pharma Live:  Nov 17 2009 1:02PM Matching: jazz pharmaceuticals inc
Jazz Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - new report	PR inside:  Nov 13 2009 5:22PM Matching: jazz pharmaceuticals inc
Jazz Pharmaceuticals to Present at Investor Conference	Pharma Live:  Nov 13 2009 7:06AM Matching: jazz pharmaceuticals inc
Promote your company here: BioNewsCast - Press Release Distribution	→View more Jazz Pharmaceuticals, Inc. news.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 277 times since April 2007, the link to the organisation's website has been followed 49 times

Search for more companies in Palo Alto

Search for more companies in California

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Jazz Pharmaceuticals, Inc.